OTC:MCRCY

CardioFlow's VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap

SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlowLibertyTM Transcatheter Aortic Valve and Retrievabl...

2024-06-17 21:32 1727